title: Histopathological findings according to Banff-97 classification system comparing tacrolimus versus cyclosporine.
authors.affiliation: Department of Nephrology, Hospital Valdecilla, Avda. Valdecilla s/n 39008, Santander, Spain.
authors.forename: E
authors.initials: E
authors.lastname: Rodrigo
authors.forename: R
authors.initials: R
authors.lastname: Escallada
authors.forename: G
authors.initials: G
authors.lastname: Fernández-Fresnedo
authors.forename: J C
authors.initials: JC
authors.lastname: Ruiz
authors.forename: C
authors.initials: C
authors.lastname: Piñera
authors.forename: I
authors.initials: I
authors.lastname: Herráez
authors.forename: J G
authors.initials: JG
authors.lastname: Cotorruelo
authors.forename: J A
authors.initials: JA
authors.lastname: Zubimendi
authors.forename: A L M
authors.initials: AL
authors.lastname: de Francisco
authors.forename: M
authors.initials: M
authors.lastname: Arias
mesh_terms: D000208:Acute Disease; D000328:Adult; D002908:Chronic Disease; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D006084:Graft Rejection / Q000453:epidemiology / Q000473:pathology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015994:Incidence; D016030:Kidney Transplantation / Q000473:pathology* / Q000706:statistics & numerical data; D008875:Middle Aged; D010336:Pathology / Q000379:methods; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus